Page last updated: 2024-09-03

lestaurtinib and Disease Exacerbation

lestaurtinib has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Attwood, K; Azabdaftari, G; Ben-Salem, S; Cortes, E; Dehm, SM; DePriest, AD; Heemers, HV; Hu, Q; Jamieson, C; Klein, E; Kumari, S; Liu, S; Magi-Galluzzi, C; Mohler, JL; Mudduluru, G; Pop, E; Senapati, D; Shah, RB; Sharifi, N; Su, Y; Venkadakrishnan, VB	1

Other Studies

1 other study(ies) available for lestaurtinib and Disease Exacerbation

Article	Year
Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy. Oncogene, 2019, Volume: 38, Issue:23 Topics: Androgens; Animals; Carbazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Progression; Furans; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Protein Kinase C; Sequence Analysis, RNA; Serum Response Factor; Transcription Factors	2019

Article

Year

Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy.

Oncogene, 2019, Volume: 38, Issue:23

Topics: Androgens; Animals; Carbazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Progression; Furans; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Protein Kinase C; Sequence Analysis, RNA; Serum Response Factor; Transcription Factors

2019